| PERIOD ENDING | 2-Oct-09 | 3-Jul-09 | 3-Apr-09 | 2-Jan-09 | | Total Revenue | 196,459 | 196,623 | 205,426 | 208,236 | | Cost of Revenue | 113,263 | 109,974 | 115,902 | 112,915 | | | Gross Profit | 83,196 | 86,649 | 89,524 | 95,321 | | | Operating Expenses | | Research Development | 13,448 | 13,718 | 14,745 | 14,514 | | Selling General and Administrative | 64,644 | 54,444 | 59,278 | 60,916 | | Non Recurring |
-
|
-
|
-
|
-
| | Others |
-
|
-
|
-
|
-
| | | | Total Operating Expenses |
-
|
-
|
-
|
-
| | | | Operating Income or Loss | 5,104 | 18,487 | 15,501 | 19,891 | | | Income from Continuing Operations | | Total Other Income/Expenses Net | 375 | 350 | 338 | 587 | | Earnings Before Interest And Taxes | 5,479 | 18,837 | 15,839 | 20,478 | | Interest Expense | 395 | 434 | 335 | 322 | | Income Before Tax | 5,084 | 18,403 | 15,504 | 20,156 | | Income Tax Expense | 3,144 | 4,950 | 5,318 | 7,115 | | Minority Interest |
-
|
-
|
-
|
-
| | | | Net Income From Continuing Ops | 1,940 | 13,453 | 10,186 | 13,041 | | | Non-recurring Events | | Discontinued Operations |
-
|
-
|
-
|
-
| | Extraordinary Items |
-
|
-
|
-
|
-
| | Effect Of Accounting Changes |
-
|
-
|
-
|
-
| | Other Items |
-
|
-
|
-
|
-
| | | | Net Income | 1,940 | 13,453 | 10,186 | 13,041 | | Preferred Stock And Other Adjustments |
-
|
-
|
-
|
-
| | | Net Income Applicable To Common Shares | $1,940 | $13,453 | $10,186 | $13,041 |
|
0.03% Nasdaq 
Income Statement
